Australia Anti-Snoring Devices Market Overview, 2031

The market for anti-snoring devices in Australia has developed into a noteworthy sector in Oceania, in line with progress in sleep health and reflecting the nation's distinct approach to healthcare. These devices aim to handle both standard snoring and obstructive sleep apnea OSA, which are increasingly acknowledged as factors leading to heart diseases, tiredness, and diminished quality of life. The presence of these devices became prominent in the early 2000s, mainly through sleep clinics in Sydney and Melbourne before branching out into retail and home health care settings. Common users are middle-aged individuals, seniors, and younger people experiencing positional snoring due to lifestyle choices. In terms of functionality, CPAP devices provide a constant airflow to keep airways clear, mandibular advancement devices MADs adjust the jaw to lessen blockage, nasal dilators enhance airflow mechanically, and EPAP devices stabilize breathing by adding resistance to exhalation. These technologies offer beneficial effects such as better sleep quality, decreased daytime sleepiness, and long-term health benefits. Australia plays a part in enhancing research and design through partnerships involving universities, sleep research centers, and device manufacturers, emphasizing ergonomic CPAP masks and lightweight oral devices. The Therapeutic Goods Administration TGA oversees certification processes to ensure safety and adherence, reinforcing confidence among consumers. As of 2025, the Australian market for anti-snoring devices is estimated to be valued at USD 450–500 million, with a growth rate of 6–7% anticipated through 2030, fueled by increasing awareness, an aging population, and robust regulatory frameworks.

According to the research report, "Australia Anti-Snoring Overview, 2031," published by Bonafide Research, the Australia Anti-Snoring market was valued at more than Australia 12.20 Million in 2025. Recent trends in Australia showcase the incorporation of smart technology and a variety of product options. Smart CPAP equipment featuring connectivity allows doctors to monitor patients remotely, while consumer-oriented wearables help assess sleep quality and the intensity of snoring, delivering immediate feedback through mobile applications. Oral devices are being enhanced using modern polymers and 3D printing methods, guaranteeing a customized fit and longevity. Nasal dilators and positional therapy tools are favored by health-conscious individuals, especially those looking for budget-friendly, non-invasive alternatives. Global brands lead the high-end CPAP market, while local companies offer specialized oral and nasal solutions that cater to the needs of the region. The distinguishing features of these products lie in their emphasis on comfort, affordability, and alignment with Australia’s healthcare framework, which prioritizes preventive care and accessibility. Distribution avenues are broadening hospital clinics continue to be crucial for CPAP prescriptions, but online shopping and retail pharmacies are quickly expanding, allowing for direct consumer sales of nasal aids, positional tools, and oral devices. Australia's best prospects stem from its aging demographic, escalating obesity rates, and a cultural focus on health maintenance. The climate is conducive to growth due to supportive regulations, strong domestic research, and consumer readiness for tech-based solutions. In the coming decade, Australia is likely to strengthen its position as a regional center for innovation in anti-snoring devices, merging international clinical standards with local engineering prowess. This combination advanced technologies for OSA management alongside accessible options for general snoring positions Australia’s market as one of the most promising in Oceania.

Australia anti snoring devices by product is divided into mandibular advancement devices MADs, tongue stabilizing devices TSDs, continuous positive airway pressure CPAP devices, nasal devices, positional therapy devices, expiratory positive airway pressure EPAP devices and others. The market for devices to combat snoring and sleep apnea in Australia is influenced by a mix of awareness in healthcare, lifestyle habits, and the use of technology. Mandibular Advancement Devices MADs dominate the market as they are effective for mild to moderate snoring and are non-invasive, enabling users to manage snoring from home without needing a doctor. Tongue Stabilizing Devices TSDs and nasal options, such as nasal dilators or strips, serve those looking for quick relief or al support along with oral appliances. There is a growing interest in positional therapy devices, especially among younger adults and those who snore from sleeping on their backs due to lifestyle choices. Expiratory Positive Airway Pressure EPAP devices are starting to be seen as an alternative to CPAP for mild Obstructive Sleep Apnea OSA, providing easy home-use options that require less upkeep. Although Continuous Positive Airway Pressure CPAP devices are very effective for moderate to severe OSA, they make up a smaller portion of the consumer market because of their higher costs and the requirement for medical oversight. Innovation is leading to product variety, with Australian consumers preferring comfortable, adjustable devices that fit their lifestyles. Local manufacturers, along with foreign suppliers, are launching smart oral devices and positional options that integrate with mobile apps to monitor compliance, track sleep, and enhance usage.

Australia anti snoring devices by type of snoring/indication is divided into primary snoring Simple Snoring and obstructive sleep apnea OSA-related snoring. The Australian market shows a distinct difference between primary snoring and snoring linked to Obstructive Sleep Apnea OSA, which leads to different product adoption trends. Primary snoring is common among city-based adults and is typically caused by lifestyle choices, anatomical differences, or sleeping positions. People who snore primarily often use oral devices, positional therapy tools, or nasal aids to enhance their sleep quality and lessen daytime tiredness without seeking medical help. On the other hand, OSA-related snoring poses more serious health threats, including risks to cardiovascular health, excessive daytime sleepiness, and metabolic issues. CPAP devices continue to be the treatment of choice for moderate to severe OSA, backed by medical supervision and ongoing care to ensure patients stick to their treatment. Nonetheless, issues with patient compliance, like discomfort or noise from the machine, have opened up opportunities for alternative options, including custom-fitted MADs and positional therapy solutions. Public health programs, initiatives to raise awareness about sleep disorders, and increased research into sleep health have boosted detection rates, especially in urban areas, resulting in a dual demand widespread solutions for simple snoring coexist with medically directed therapies for OSA, reflecting both consumer preferences and evidence-based practices in medicine.

Australia anti snoring devices by distribution channel is divided into E-commerce/Online Platforms and other hypermarkets/supermarkets, specialty stores. Australia's channels for distributing anti-snoring products are varied, blending medical paths, retail systems, and online services. Hospitals and sleep treatment centers act as key providers for diagnosis and treatment devices, particularly CPAP machines and custom-fitted oral products, which include consultation, monitoring of adherence, and education for patients. Retail pharmacies, specialized health stores, and medical device outlets offer access to non-prescription choices such as oral devices, nasal aids, and positional therapy tools, designed for those handling mild snoring on their own. Online shopping sites have experienced significant growth, allowing consumers to easily buy devices, compare features, and use home delivery services, especially in more rural areas. The integration of telehealth, which includes remote checks for CPAP usage and follow-up advice, has also increased access for patients who are far from clinics. This multi-faceted distribution approach provides a balance between clinical oversight for serious cases and easy, affordable solutions for at-home care, ensuring wide market reach and encouraging use among city and regional residents. The strong ecosystem in the Australian market backs both preventive and therapeutic snoring treatments, reflecting a consumer-oriented strategy alongside organized healthcare support.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Anti-snoring Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By product
• Mandibular Advancement Devices (MADs)
• Tongue Stabilizing Devices (TSDs)
• Continuous Positive Airway Pressure (CPAP) Devices
• Nasal Devices
• Positional Therapy Devices
• Expiratory Positive Airway Pressure (EPAP) Devices
• Others

By Type of Snoring/Indication
• Primary Snoring (Simple Snoring)
• Obstructive Sleep Apnea (OSA)-Related Snoring

By Distribution Channel
• Retail Pharmacies & Drug Stores
• Hospital & Sleep Clinics
• E-commerce/Online Platforms (A rapidly growing segment due to DTC brands)
• Other (Hypermarkets/Supermarkets, Specialty Stores)